Defending champion Carlos Alcaraz has announced that he will not take part in next month’s French Open after medical examinations revealed a wrist injury that requires caution. The world No.
2 made the decision public on Friday via a social‑media post, explaining that the tests conducted that day indicated the safest course of action is to sit out both the Rome Masters and Roland Garros while doctors monitor his recovery and determine when he can safely return to competitive play. Alcaraz’s statement read, "Following the results of today’s medical assessments, we have decided that the most prudent approach is to be cautious and skip both Rome and Roland Garros, while we wait to assess the evolution and decide when we will be back on court." This announcement means that the seven‑time Grand Slam champion will miss the opportunity to defend the title he captured in a dramatic showdown against Jannik Sinner last year.
The 2024 final was a historic marathon that lasted five hours and 29 minutes, with Alcaraz saving three championship points before prevailing 4‑6, 6‑7 (4‑7), 6‑4, 7‑6 (7‑3), 7‑6 (10‑2). The victory cemented his place among the sport’s greats and set the stage for an intense rivalry with Sinner, who had reclaimed the world No.
1 ranking after beating Alcaraz in the Monte Carlo Masters final earlier in the season. Alcaraz’s recent résumé is impressive.
In addition to his French Open triumph, he reclaimed the world No. 1 spot by winning the US Open for a second time in 2025 and captured his first Australian Open title earlier this year, becoming the youngest player ever to complete a career Grand Slam at 22 years and 258 days old. These achievements underscored his status as the sport’s dominant force on all surfaces. However, the wrist problem resurfaced during the Barcelona Open, where Alcaraz underwent treatment after his opening‑round win over Otto Virtanen.
The injury forced him to withdraw not only from the French Open but also from the upcoming Madrid Open, despite earlier optimism that he might still compete in Paris. At the Laureus Sports Awards, where he was named Sportsman of the Year, Alcaraz hinted at a possible return, saying, "We'll see.
The next medical test will be crucial." Unfortunately, subsequent test results confirmed that he must sit out the second Grand Slam of the year and the lead‑up events in Rome, effectively ending his chances of defending his Roland Garros crown. This development opens a clear path for Jannik Sinner to complete his own career Grand Slam. Sinner, who already holds two Australian Open titles, a Wimbledon crown from last year, and the 2024 US Open, will now have the opportunity to add a French Open title to his collection.
Sinner learned of Alcaraz’s withdrawal during a post‑match interview after defeating Benjamin Bonzi in the second round of the Madrid Open. He expressed sympathy, stating, "It’s sad for tennis.
As a competitor, I always want to play against the best in the world, and he definitely is the best on this surface. I wish him a speedy recovery." Tennis analyst Naomi Broady of Sky Sports commented on the situation, noting, "You have to feel for him. This is one of his first truly significant injuries. Missing Madrid, the biggest tournament in his home country, was already a blow, but having to sit out Rome and Roland Garros as well is a huge setback.
It shows how serious the injury is when a player has to miss a Grand Slam. It’s a massive missed opportunity for him and gives Sinner a chance to pull further ahead as world No. 1." Alcaraz’s withdrawal not only reshapes the immediate competitive landscape but also raises broader questions about player health and the demanding clay‑court season.
The French Open, traditionally the most physically taxing of the four majors, often forces players to manage injuries carefully. Alcaraz’s decision highlights the importance of prioritizing long‑term health over short‑term glory, especially for a young star whose career could span many more years.
Fans and pundits alike will be watching closely as Alcaraz undergoes rehabilitation. The medical team will likely focus on strengthening the wrist, improving flexibility, and ensuring that any underlying issues are fully resolved before he returns to the tour.
In the meantime, the ATP calendar will continue without him, and the spotlight will shift to other emerging talents and established stars eager to capitalize on his absence. The French Open will proceed with a revised draw, and while the tournament will undoubtedly produce high‑quality tennis, the narrative will be missing one of its brightest protagonists. For now, the tennis world wishes Carlos Alcaraz a swift and complete recovery, hoping he will be back on the clay courts next season, ready to challenge for more titles and continue his remarkable ascent in the sport.